相关实验视频
Updated: May 15, 2026

08:28
Development of an In Vitro Ocular Platform to Test Contact Lenses
Published on: April 6, 2016
10.6K
使用SimVis Gekko模拟每日软多焦隐形眼镜:从体外和计算表征到临床验证
Eduardo Esteban-Ibañez1,2, Diego Montagud-Martínez3,4, Lucie Sawides5,6
12EyesVision SL, Plaza de la Encina, 10, Nucleo 3, Planta 4ª, 28760, Tres Cantos, Madrid, Spain. eesteban@2eyesvision.com.
Scientific reports
|April 13, 2024
概括
视觉模拟器准确地预测了多焦点隐形眼镜 (MCL) 在长视障碍纠正方面的性能. 这项研究验证了SimVis Gekko对真实MCL的模拟,显示了高相关性和低误差,为更快的患者适应铺平了道路.
科学领域:
- 眼科光学 眼科光学
- 视觉光学是一种视觉光学.
- 隐形眼镜技术 隐形眼镜技术
背景情况:
- 多焦点隐形眼镜 (MCL) 为长视障碍的纠正提供了一个解决方案.
- 广泛采用MCLs是有限的,可能是由于适应挑战.
- 视觉模拟器可以帮助完善MCL适应过程.
研究的目的:
- 使用SimVis Gekko视觉模拟器生成每日软MCL设计的准确模拟.
- 通过体外表征和临床测试与长视患者验证这些模拟.
主要方法:
- 使用NIMO TR-1504.4进行MCL (权力,补充) 的体外表征.
- 阶段图的重建和透过焦视觉斯特雷尔度量计算.
- 使用SimVis Gekko进行计算模拟,然后进行实验室和临床验证.
主要成果:
- SimVis Gekko模拟显示,通过焦视敏度 (TF-VA) 和不同距离的视敏度与真实MCL有很好的一致性.
- 在模拟和真实TF-VA之间观察到高部分相关性 (>0.90) 和低根平均平方误差 (<0.07 logMAR).
- 临床验证证实了模拟方法的准确性.
结论:
- 与体外测量相结合的SimVis Gekko视觉模拟器,为模拟MCL性能提供了一个有效的方法.
- 这种经过验证的模拟方法有可能加速使用MCL的长视患者的适应过程.
相关概念视频
In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

